Invitation: Participation in community engagement survey
Background & purpose
Greetings on behalf of the Stakeholder & Community
Engagement Workgroup (SCE-WG) of the Critical Path to TB Drug
Regimens initiative (CPTR). The CPTR Initiative is a
cross-sector program that aims to greatly reduce the time needed
to develop and make available novel drug regimens for
tuberculosis. The CPTR SCE-WG is charged with developing tools
and resources to support and promote better stakeholder
engagement and participatory practices in TB research.
There
is growing consensus among biomedical researchers that
stakeholder and community engagement (SCE) can make tremendous
contributions to the outcomes of clinical trials. Two important
recent advances in the field of tuberculosis could help
facilitate effective SCE. First, the release of tools and
resources, such as the Good Participatory Practice Guidelines
for Tuberculosis Drug Trials (GPP-TB), have helped articulate
common language and offer strategies to help nurture the
engagement process. Second, there has been promising progress in
incorporating rigorous evaluation processes into SCE programs.
However, in spite of these advances, two challenges remain.
First, there continues to be a dearth of published empirical
evidence measuring the impact of community and stakeholder
engagement in tuberculosis. Second, without this evidence,
current cutbacks in funding to tuberculosis research could
jeopardise the budding support for SCE programs.
This survey will be used as a tool to help compile examples of community engagement and GPP in practice. We would like to highlight the overall impact, as observed, on research/clinical trial conduct. These examples will help to call attention to the important role of SCE programs as well as the need for both new and sustained investment in SCE.
The survey can be accessed here:
https://www.surveymonkey.com/s/CPTR-CESurvey2014.